Academic Journal

Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults

التفاصيل البيبلوغرافية
العنوان: Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults
المؤلفون: Drew Provan, Tom Butler, Maria Laura Evangelista, Sergio Amadori, Adrian C. Newland, Roberto Stasi
المصدر: Haematologica, Vol 92, Iss 12 (2007)
بيانات النشر: Ferrata Storti Foundation, 2007.
سنة النشر: 2007
المجموعة: LCC:Diseases of the blood and blood-forming organs
مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5
الوصف: We conducted a retrospective analysis of 11 consecutive patients with various autoimmune cytopenias who failed to respond to conventional treatments and received a fixed-dose regimen of rituximab (100 mg weekly for 4 consecutive weeks). Sustained complete responses were achieved in 4 out of 7 patients with idiopathic thrombocytopenic purpura and in 1 patient with autoimmune pancytopenia. A partial response was observed in 1 patient with autoimmune hemolytic anemia. The immunotherapy had no effect in 1 patient with pure red cell aplasia or in 1 patient with autoimmune neutropenia. No infusion-related or delayed toxicities attributable to rituximab were experienced by any of the patients.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 0390-6078
1592-8721
Relation: https://haematologica.org/article/view/4672; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721
DOI: 10.3324/haematol.11709
URL الوصول: https://doaj.org/article/2e59b163a3f5484a81d6beec9a856c31
رقم الانضمام: edsdoj.2e59b163a3f5484a81d6beec9a856c31
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:03906078
15928721
DOI:10.3324/haematol.11709